XML 125 R98.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenue:        
Revenue   $ 170,155 $ 227,043 $ 251,455
Segment research and development expense        
Research and development   243,773 424,061 580,621
Segment general and administrative expense        
General and administrative   183,290 246,161 385,025
Segment operating (loss) income:        
Total segment operating loss   (315,278) (559,757) (864,406)
Reconciling items to reconcile total segment operating loss to loss before income taxes:        
Stock-based compensation   81,546 112,344 229,884
Impairment expense   0 4,823  
Depreciation and amortization   58,990 63,020 70,507
Restructuring charges   11,398 24,172 0
Carrying cost of excess space (net of sublease income)   76,283 72,924 65,406
Other (expense) income, net   (1,678) (12,249) 28,534
Loss before income taxes   (313,600) (547,508) (892,940)
Employer payroll taxes   1,200 3,000 5,000
Goodwill impairment $ 47,900 0 47,858 0
Service        
Revenue:        
Revenue   37,409 53,071 78,975
Segment cost of revenue        
Total segment cost of revenue   31,521 38,549 46,524
Product        
Revenue:        
Revenue   0 0 28,949
Segment cost of revenue        
Total segment cost of revenue   0 0 7,481
Lab equipment        
Reconciling items to reconcile total segment operating loss to loss before income taxes:        
Impairment expense     5,800  
Goodwill impairment       25,200
Lease Assets        
Reconciling items to reconcile total segment operating loss to loss before income taxes:        
Goodwill impairment       96,200
Corporate, Non-Segment        
Reconciling items to reconcile total segment operating loss to loss before income taxes:        
Stock-based compensation   82,704 115,299 234,908
Impairment expense   0 53,654 121,404
Depreciation and amortization   58,990 63,020 70,507
Restructuring charges   11,398 24,172 0
Carrying cost of excess space (net of sublease income)   53,723 25,986 0
Merger and acquisition related expenses   (5,998) 4,417 61,188
Acquired in-process research and development   0 19,849 9,582
Other (expense) income, net   (1,678) (8,075) 28,535
Cell Engineering and Biosecurity | Operating Segments        
Segment operating (loss) income:        
Total segment operating loss   (114,461) (249,186) (366,816)
Cell Engineering        
Revenue:        
Revenue   132,746 173,972 143,531
Segment cost of revenue        
Total segment cost of revenue   13,203 5,999 0
Segment research and development expense        
Research and development   158,541 271,512 335,943
Segment general and administrative expense        
General and administrative   56,532 115,028 171,210
Segment operating (loss) income:        
Total segment operating loss   (95,530) (218,567) (363,622)
Biosecurity        
Segment research and development expense        
Research and development   0 771 1,599
Segment general and administrative expense        
General and administrative   27,443 44,370 55,514
Segment operating (loss) income:        
Total segment operating loss   (18,931) (30,619) (3,194)
Biosecurity | Service        
Revenue:        
Revenue   37,409 53,071 78,975
Segment cost of revenue        
Total segment cost of revenue   28,897 38,549 46,524
Biosecurity | Product        
Revenue:        
Revenue   0 0 28,949
Segment cost of revenue        
Total segment cost of revenue   $ 0 $ 0 $ 7,481